forefront – Lab DB

J&J Positions Spravato Remission Data at Forefront of Treatment-Resistant Depression Growth Strategy

Lana Keisha Jul 12, 2026 0

Johnson & Johnson (J&J) is intensifying its marketing efforts for Spravato (esketamine) by spotlighting compelling remission rate data for treatment-resistant…

J&J Positions Spravato Remission Data at Forefront of Treatment-Resistant Depression Growth Strategy

YOU MAY HAVE MISSED

J&J Positions Spravato Remission Data at Forefront of Treatment-Resistant Depression Growth Strategy

Early Adulthood Alcohol Consumption Linked to Permanent Brain Changes and Cognitive Decline in Middle Age

New solid-state material converts sunlight into higher-energy UV light

Invasive Goldfish Trigger a Regime Shift in Experimental Lake Ecosystems of Varying Trophic State